Literature DB >> 25596352

Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.

Yongfang Yuan1, Hai Zhang2, Fengfeng Sun3, Sen Sun3, Zhenyu Zhu4, Yifeng Chai5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Asiatic acid is one of the main components in the herb Centella asiatica, which is a well-known herbal medicine for its excellent pharmacological effects. To enhance the development potentials of asiatic acid as a chemopreventative agent, there is a great need to further understand its biopharmaceutical and pharmacokinetic properties. The aim of this research is to clarify the mechanisms of absorption and metabolism of asiatic acid, and explore its biopharmaceutical and pharmacokinetic properties in rats by using a sensitive and robust HPLC-MS method.
MATERIALS AND METHODS: Male Sprague-Dawley rats were randomly assigned to 2 groups and administered with asiatic acid by oral and intravenous administration. Plasma concentrations of asiatic acid were determined at designated points and main pharmacokinetic parameters were estimated. The absorption of asiatic acid was investigated by using Caco-2 cell line absorption model in vitro and rat intestinal perfusion model in situ. The metabolic rate of asiatic acid was investigated by incubating it in rat liver microsome system in vitro. In addition, the solubility of asiatic acid in aqueous solution was also determined by using HPLC-MS method.
RESULTS: The absolute oral bioavailability of asiatic acid is 16.25%. It was found that the permeability of asiatic acid is more than 10(-5) in the Caco-2 cell monolayer and rat intestinal perfusion model, and its main absorption region is the jejunum in rats. The metabolic rate of asiatic acid in rat liver microsomes, t1/2, is 9.493min, which shows that asiatic acid can be metabolized rapidly. The solubility of aisiatic acid was 0.1583mgmL(-1), and its poor solubility will result in low bioavailability.
CONCLUSIONS: The asiatic acid in a variety of matrixes was analyzed by using a sensitive and specific HPLC-MS method, and its absolute oral bioavailability in rats was very low. Asiatic acid can be metabolized rapidly in rat liver microsomes, and has good permeability across Caco-2 monolayer cell and rat intestine perfusion. It can be deduced that the low bioavailability of asiatic acid results from poor solubility and rapid metabolism.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Absorption; Asiatic acid; Biopharmaceutics; HPLC–MS; Metabolism; Pharmacokinetics

Mesh:

Substances:

Year:  2015        PMID: 25596352     DOI: 10.1016/j.jep.2015.01.006

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

2.  Centella asiatica - Phytochemistry and mechanisms of neuroprotection and cognitive enhancement.

Authors:  Nora E Gray; Armando Alcazar Magana; Parnian Lak; Kirsten M Wright; Joseph Quinn; Jan F Stevens; Claudia S Maier; Amala Soumyanath
Journal:  Phytochem Rev       Date:  2017-09-20       Impact factor: 5.374

3.  Effects of glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism.

Authors:  Ling Guo; Ying Cui; Kaijun Hao
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

4.  Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of Centella asiatica.

Authors:  Nor Atiqah Jusril; Ain Nur Najihah Muhamad Juhari; Syahrul Imran Abu Bakar; Wan Mazlina Md Saad; Mohd Ilham Adenan
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

Review 5.  Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies.

Authors:  Niege A J C Furtado; Laetitia Pirson; Hélène Edelberg; Lisa M Miranda; Cristina Loira-Pastoriza; Véronique Preat; Yvan Larondelle; Christelle M André
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

Review 6.  Tetracyclic and Pentacyclic Triterpenes with High Therapeutic Efficiency in Wound Healing Approaches.

Authors:  Roxana Ghiulai; Oana Janina Roşca; Diana Simona Antal; Marius Mioc; Alexandra Mioc; Roxana Racoviceanu; Ioana Macaşoi; Tudor Olariu; Cristina Dehelean; Octavian Marius Creţu; Mirela Voicu; Codruţa Şoica
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

7.  Pre-infection administration of asiatic acid retards parasitaemia induction in Plasmodium berghei murine malaria infected Sprague-Dawley rats.

Authors:  Greanious Alfred Mavondo; Blessing Nkazimulo Mkhwananzi; Musa Vuyisile Mabandla
Journal:  Malar J       Date:  2016-04-21       Impact factor: 2.979

8.  Nerve Protective Effect of Asiaticoside against Ischemia-Hypoxia in Cultured Rat Cortex Neurons.

Authors:  Tao Sun; Bin Liu; Peng Li
Journal:  Med Sci Monit       Date:  2015-10-08

9.  Integration of mass spectral fingerprinting analysis with precursor ion (MS1) quantification for the characterisation of botanical extracts: application to extracts of Centella asiatica (L.) Urban.

Authors:  Armando Alcazar Magana; Kirsten Wright; Ashish Vaswani; Maya Caruso; Ralph L Reed; Conner F Bailey; Thuan Nguyen; Nora E Gray; Amala Soumyanath; Joseph Quinn; Jan F Stevens; Claudia S Maier
Journal:  Phytochem Anal       Date:  2020-04-12       Impact factor: 3.373

10.  3β,23-Dihydroxy-12-ene-28-ursolic Acid Isolated from Cyclocarya paliurus Alleviates NLRP3 Inflammasome-Mediated Gout via PI3K-AKT-mTOR-Dependent Autophagy.

Authors:  Dongxiao Lou; Xiaogai Zhang; Cuihua Jiang; Fang Zhang; Chao Xu; Shengzuo Fang; Xulan Shang; Jian Zhang; Zhiqi Yin
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.